Literature DB >> 31608447

Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers.

Xiaoqian Liu1,2, David J Hunter1,2, Jillian Eyles1,2, Andrew J McLachlan3, Jeffry Adiwidjaja3, Shane K Eagles3,4, XiaoSuo Wang4.   

Abstract

OBJECTIVES: Dietary supplements are increasingly used by people with osteoarthritis. Boswellia serrata extract, curcumin, pine bark extract and methylsulfonylmethane have been identified as having the largest effects for symptomatic relief in a systematic review. It is important to understand whether any pharmacokinetic interactions are among the major constituents of these supplements so as to provide information when considering the combination use of these supplements. The aim of this study was to investigate the pharmacokinetics of the constituents alone and in combination.
METHODS: This study was a randomized, open-label, single-dose, four-treatment, four-period, crossover study with 1-week washout. The pharmacokinetics of the constituents of these supplements when dosed in combination with methylsulfonylmethane were compared to being administered alone. Plasma samples were obtained over 24 h from 16 healthy participants. Eight major constituents were analysed using a validated ultra-high-performance liquid chromatography-tandem mass spectrometry assay. KEY
FINDINGS: The pharmacokinetics of each constituent was characterized, and there were no significant differences in the pharmacokinetic profiles of the constituents when administered as a combination, relative to the constituents when administered alone (P > 0.05).
CONCLUSIONS: These data suggest that interactions between the major constituents of this supplement combination are unlikely and therefore could be investigated to manage patients with osteoarthritis without significant concerns for possible pharmacokinetic interactions.
© 2019 Royal Pharmaceutical Society.

Entities:  

Keywords:  Boswellia serrata extract; curcumin; interaction; pharmacokinetics; pine bark extract

Mesh:

Substances:

Year:  2019        PMID: 31608447     DOI: 10.1111/jphp.13184

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Prospective, Multicenter Evaluation of a Polyherbal Supplement alongside Standard-of-Care Treatment for Mild Knee Osteoarthritis.

Authors:  Zbigniew Żęgota; Joanna Goździk; Joanna Głogowska-Szeląg
Journal:  Adv Orthop       Date:  2021-05-07

2.  Efficacy and safety of a supplement combination for hand osteoarthritis pain: protocol for an internet-based randomised placebo-controlled trial (The RADIANT study).

Authors:  Xiaoqian Liu; Sarah Robbins; Jillian Eyles; Tatyana Fedorova; Sonika Virk; Leticia A Deveza; Andrew McLachlan; David Hunter
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

Review 3.  Emerging Natural-Product-Based Treatments for the Management of Osteoarthritis.

Authors:  Maria-Luisa Pérez-Lozano; Annabelle Cesaro; Marija Mazor; Eric Esteve; Sabine Berteina-Raboin; Thomas M Best; Eric Lespessailles; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2021-02-09

Review 4.  Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis.

Authors:  Vidhu Sethi; Manohar Garg; Maxime Herve; Ali Mobasheri
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-22       Impact factor: 3.625

5.  A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster).

Authors:  Emily K Donovan; Sophia Kekes-Szabo; Joanne C Lin; Rebecca L Massey; James D Cobb; Kathleen S Hodgin; Timothy J Ness; Carl Hangee-Bauer; Jarred W Younger
Journal:  Int J Environ Res Public Health       Date:  2021-03-03       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.